DrugBank ID: db12941
Drug Sentece Context
Table 1. Analysis of context sentence of darolutamide gene in 2 abstracts.
|32549073||In metastatic as well as castration resistant PCa stages, adding androgen receptor targeted agents (abiraterone, apalutamide, darolutamide or enzalutamide) to androgen-deprivation therapy (ADT) could be considered in high risk patients. […] In regard to metastatic and castration resistant PCa, combination therapies with abiraterone, apalutamide, darolutamide or enzalutamide could be considered.|